The quantitative data are shown as the estimated margin mean (EMM) ± standard error (SE) (for comparison between 2 groups), median with interquartile range (IQRs) or mean ± standard deviation (SD), depending on their distribution. Categorical data are presented as numbers with percentages. Pearson's Chi-squared test with or without Yete's continuity correction or Fisher's exact test was used to compare all-cause mortality, RC and recurrence/new lesions between the groups. Kaplan–Meier curves and the Breslow-Wilcoxon test were used to depict and compare the MAFS and TAFS. The significance level was set at 0.05 for all statistical tests. A linear mixed model was used to analyze the effects of cell type on the longitudinal changes in the continuous variables and to determine the presence of any interactions between the individual groups and the time point. The Wilcoxon signed-rank test was used to compare the QoL scores at baseline and at 1 year, 3 years and 5 years posttransplantation. All tests were performed using PASW software, version 19 (IBM Corporation, Armonk, NY, USA).
Pasw software version 19
Manufactured by IBM
Sourced in United States, United Kingdom
PASW software, version 19, is a statistical analysis tool developed by IBM. It provides users with a suite of data management and analysis functions. The software allows for the manipulation, analysis, and presentation of data.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using pasw software version 19
1
Longitudinal Assessment of Cell Therapies
2
Stem Cell Therapy for Wound Healing
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The quantitative data are shown as the estimated margin mean (EMM) ± SE (for comparison between two groups), mean ± SD, or as the median with the interquartile range (IQR), depending on their distribution. The categorical data are presented as numbers with percentages. Pearson's chi‐square test with or without Yete's continuity correction or Fisher's exact test was used to compare the groups in relation to all‐cause mortality, complete wound healing, rest pain alleviation, Rutherford class, and recurrence/new lesions. A linear mixed model was used to analyze the effects of the cell type on the longitudinal changes in the continuous variables and to determine the presence of any interactions between the individual groups and the time point. The Wilcoxon signed‐rank test was used to compare the QoL scores at baseline and at 1 year and 3 years after transplantation. Kaplan‐Meier curves and the Breslow‐Wilcoxon test were used to depict and compare the MAFS, TAFS, and rest pain relief probabilities. The significance level was set at .05 for all statistical tests.9 The statistical analyses were performed using PASW software, version 19 (IBM Corporation, Armonk, New York) and GraphPad Prism version 5.0 (La Jolla, California).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!